| Current Price | $4.23 | Mkt Cap | $858.5M |
|---|---|---|---|
| Open | $4.74 | P/E Ratio | 0.00 |
| Prev. Close | $4.23 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $4.14 - $4.74 | Volume | 812,052 |
| 52-Wk Range | $1.82 - $5.63 | Avg. Daily Vol. | 3,215,985 |
A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.
| Current Price | $4.23 | Mkt Cap | $858.5M |
|---|---|---|---|
| Open | $4.74 | P/E Ratio | 0.00 |
| Prev. Close | $4.23 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $4.14 - $4.74 | Volume | 812,052 |
| 52-Wk Range | $1.82 - $5.63 | Avg. Daily Vol. | 3,215,985 |
The best Bull and Bear pitches based on recency and number of recommendations.
I'm an Agenus skeptic but I think there's a good chance of a rebound ahead of topline data from the phase II trial of HerpV therapeutic herpes simplex 2 vaccine expected in Q4 2013. A good bellwether for the trial results will be if Agenus decides to… More
I think there's a solid industry of creating biotech companies with no hope of real profits and milking/bilking investors. If my parents had been more Bernie Madoff and less Andy Griffith I would definitely start one. 1- Find an aging biology… More
Read the most recent pitches from players about AGEN.
Recs
TerryHogan
(99.95)
Submitted: 10/4/2018 3:14:42 AM :
Start Price:
$2.16
NASDAQ:AGEN Score:
-81.47
I think there's a solid industry of creating biotech companies with no hope of real profits and milking/bilking investors. If my parents had been more Bernie Madoff and less Andy Griffith I would definitely start one. 1- Find an aging biology professor with a couple of published papers tangential to a fadish disease treatment. 2. - Over a dinner and some scotch, convince him he's a genius and together you can be rich and save the world. 3. Look at a few other scammy biotech firms and recruit a board of directors that have 'proven experience'. 4. Raise a bit of capital from some alumni. 5. Go public. 6. Alternate between issuing press releases and issuing shares. 7. Collect large salary & stock options. Not saying that's what's going on with this company, but it definitely is happening out there.
Recs
rocknrook
(60.63)
Submitted: 6/27/2017 7:53:50 AM :
Start Price:
$4.01
NASDAQ:AGEN Score:
-30.92
Assuming effective test results. I like that there is significant interest from big players in partnering.
Recs
zzlangerhans
(98.70)
Submitted: 4/3/2013 1:23:04 AM :
Start Price:
$3.94
NASDAQ:AGEN Score:
-103.45
I'm an Agenus skeptic but I think there's a good chance of a rebound ahead of topline data from the phase II trial of HerpV therapeutic herpes simplex 2 vaccine expected in Q4 2013. A good bellwether for the trial results will be if Agenus decides to raise ahead of data. If they do, expect disappointment ahead.
Find the members with the highest scoring picks in AGEN.
svande8952 (84.90) Score: +325.73
The Score Leader is the player with the highest score across all their picks in AGEN.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| svande8952 | 84.90 | 6/16/2009 |
|
5Y | $12.24 | -65.60% | +260.12% | +325.73 | 1 Comment | |
| 1or5stars | 99.16 | 6/8/2009 |
|
3W | $13.68 | -69.23% | +255.65% | +324.87 | 0 Comment | |
| TWreckz | 98.51 | 6/5/2009 |
|
5Y | $15.90 | -73.52% | +249.41% | +322.94 | 0 Comment | |
| rcbaldwinjr | 81.30 | 8/5/2009 |
|
3W | $13.85 | -69.61% | +232.75% | +302.36 | 0 Comment | |
| rhinomaj | 56.09 | 8/4/2009 |
|
3M | $14.34 | -70.64% | +230.66% | +301.30 | 0 Comment | |
| epc53 | 27.53 | 8/7/2009 |
|
5Y | $13.26 | -68.25% | +228.78% | +297.03 | 0 Comment | |
| chop3399 | < 20 | 3/13/2008 |
|
5Y | $13.44 | -68.68% | +165.59% | +234.27 | 0 Comment | |
| JackOffBadApples | 74.15 | 9/12/2008 |
|
3W | $10.02 | -57.98% | +174.14% | +232.13 | 0 Comment | |
| ortiz176 | 58.62 | 4/14/2008 |
|
1Y | $15.48 | -72.80% | +158.36% | +231.17 | 0 Comment | |
| DayTr8der88 | < 20 | 9/22/2008 |
|
NS | $9.90 | -57.47% | +171.99% | +229.47 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
